IMMUPHARMA PLC
IMM | IL
Overview
Corporate Details
- ISIN(s):
- GB0033711010
- LEI:
- 213800VZKGHXC7VUS895
- Country:
- United Kingdom
- Address:
- One, EC1A 7BL London
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
Induction Healthcare improves healthcare team-patient interactions. Our patient portal streamlines care with appointment scheduling, digital forms, and video consultations, boosting efficiency and integration with existing hospital systems.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-12 13:51 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 19.8 KB | |
| 2025-05-27 16:13 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.0 KB | |
| 2025-03-14 08:00 |
Regulatory News Service
IMM attending Bio-Europe Spring 17-19 March,Milan
|
English | 15.9 KB | |
| 2025-03-13 08:00 |
Regulatory News Service
ImmuPharma proves unique Mechanism of Action-P140
|
English | 18.0 KB | |
| 2025-02-21 12:36 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.0 KB | |
| 2025-02-13 08:00 |
Regulatory News Service
£2.91m fundraising; related party transactions
|
English | 56.0 KB | |
| 2025-01-28 13:57 |
Regulatory News Service
Response to Share Price Movement
|
English | 13.9 KB | |
| 2025-01-09 08:00 |
Regulatory News Service
Breakthrough Findings into Autoimmune Diseases
|
English | 18.3 KB | |
| 2025-01-08 08:00 |
Regulatory News Service
IMM at JP MORGAN CONFERENCE & BIOTECH SHOWCASE
|
English | 14.7 KB | |
| 2024-12-23 08:00 |
Regulatory News Service
Change of Auditor
|
English | 11.2 KB | |
| 2024-12-10 15:36 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.1 KB | |
| 2024-12-04 08:00 |
Regulatory News Service
Appointment of Company Secretary
|
English | 14.4 KB | |
| 2024-09-09 08:01 |
Regulatory News Service
Extension of Warrants in Incanthera to 31 Mar 2025
|
English | 20.6 KB | |
| 2024-09-09 08:00 |
Earnings Release
Half-year Report
|
English | 327.1 KB | |
| 2024-08-06 14:41 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Revenio Group Oyj | Finland | REG1V | |
|
Telemedycyna Polska Spolka Akcyjna | Poland | TMP | |
|
TISSUE REGENIX GROUP PLC | United Kingdom | TRX | |
|
TRELLUS HEALTH PLC | United Kingdom | TRLS | |
|
VERICI DX PLC | United Kingdom | VRCI | |
|
Vidavo S.A. | Greece | VIDAV | |
|
ViroGates A/S | Denmark | VIRO | |
|
Xvivo Perfusion | Sweden | XVIVO | |
|
Yoshi Innovation Spolka Akcyjna | Poland | YOS |